A new policy mandate from Belize’s Ministry of Health and Wellness requiring a doctor’s prescription for all hormonal contraceptives — including birth control pills, patches, and injections — has ignited fierce debate over reproductive health access across the country, scheduled to take effect ahead of 2026.
In an official advisory released by the ministry, regulators framed the new requirement as a critical public safety measure. Officials argue that hormonal contraception carries meaningful physiological side effects and health risks, and mandatory medical oversight will ensure patients receive personalized guidance to use these products safely. The policy changes longstanding rules that allowed many hormonal contraceptives to be purchased over the counter without a physician’s approval.
But the shift has drawn sharp pushback from longstanding reproductive health advocacy groups, who warn the rule will create crippling new barriers to care for the nation’s most vulnerable women and girls. Joan Burke, founding executive director of the Belize Family and Life Association (BFLA), an organization that has worked to reduce unintended adolescent pregnancy since 1985, called the policy a major step backward that could undo 40 years of progress expanding reproductive autonomy in Belize.
Burke’s primary criticism centers on the new cost burden the rule imposes on patients. Where a month’s supply of birth control pills previously cost as little as $10 purchased over the counter, the added requirement of a paid doctor’s consultation pushes the total cost to $85 or more per cycle. For low-income women, those living in remote rural areas with limited access to affordable healthcare, and women in abusive or controlling relationships where they do not have independent access to funds, this cost increase is not just an inconvenience — it is an insurmountable barrier that will cut off access to contraception entirely.
“Just imagine having to find $85 for a month, getting that $85 from the person who basically controls you every day,” Burke explained in an interview commenting on the new rule. She warned that cutting off widespread access to reliable contraception will lead to measurable public health harms: rising rates of unintended teen pregnancy, increased maternal mortality, and a spike in deaths linked to unsafe, unregulated clandestine abortions.
Notably, Burke emphasized that the BFLA does not oppose medical consultations for contraception — in fact, the group actively encourages women to seek medical guidance before starting any new hormonal birth control method. The organization’s objection is to the government’s decision to make a prescription a mandatory legal requirement, rather than leaving access open for patients to choose to consult a provider on their own timeline.
“But to have it that a prescription is required, I am not in favour of that. We are putting so many women and girls at risk by that decision,” Burke said. She also questioned whether the government conducted sufficient public consultation with reproductive health stakeholders before implementing the policy, calling on officials to revisit the rule. “For a decision such as that to be made, I don’t know what level of consultation was done. Let’s rethink this.”
